Advertisement|Remove ads.

Shares of Quantum Cyber (QUCY) are getting significant investor attention on Tuesday after the company said it has taken full control of its drone production operations, thereby eliminating its dependence on third-party supply chains.
At the time of writing, QUCY stock was up nearly 30% in premarket trading.
Quantum Cyber, which made a complete U-turn from pharmaceuticals to defense earlier this year, said it has revised the terms of its prior agreement with BP United to assume direct responsibility for manufacturing licensed drone products.
The company said the decision to take over its own production reflects its transition from a technology development and licensing platform to a vertically integrated autonomous defense manufacturer.
BP United will continue to provide the company with technical assistance and consulting services under revised terms, with Quantum Cyber retaining the exclusive perpetual license to BP United's autonomous drone technology portfolio, and full discretion to establish and operate its own manufacturing facilities.
“We are not building a licensing company. We are building a manufacturing platform, and taking direct control of production of the drone technology at the core of our portfolio is the logical next step in that build,” said CEO David Lazar. “BP United's technical support, combined with our own manufacturing infrastructure, gives us the supply chain discipline and operational control that a defense platform of this scale requires."
Additionally, BP United has agreed to vote all ordinary shares of Quantum Cyber it holds in favor of any proposal recommended by the company for the next two years.
“The voting agreement reinforces the alignment of interests between Quantum Cyber and its technology partner, providing the company's board of directors with governance support as it executes its platform assembly strategy,” according to a public statement.
On Stocktwits, retail sentiment surrounding the stock remained ‘bearish’ amid a sixfold rise in message volumes over the last 24 hours.
One user on the platform said in-house manufacturing eliminates the risk of third-party delays, specifically addressing a core concern of the Trump administration's production initiative.
QUCY stock has more than doubled in value so far this year and climbed more than 44% over the last 12 months, outperforming the benchmark S&P index.
For updates and corrections, email newsroom[at]stocktwits[dot]com.